EVOMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 571,081 | 489,530 | 712,405 | 424,834 | 415,887 | 318,081 | 218,668 | 215,146 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 31,470 | 20,822 | 117,738 | 9,799 | 22,407 | -24,548 | -837 | -30,583 |
| Equity | 303,986 | 324,808 | 442,546 | 287,639 | 310,046 | 285,498 | 284,656 | 254,073 |
| Liabilities | 0 | 116,786 | 116,621 | 87,700 | 92,801 | 63,948 | 71,660 | 89,941 |
| Non-current assets | 11,800 | 9,928 | 7,868 | 11,286 | 9,272 | 9,433 | 5,703 | 3,779 |
| Current assets | 345,048 | 427,940 | 548,064 | 360,466 | 389,776 | 335,518 | 347,181 | 336,890 |
| Total assets | 356,848 | 437,868 | 555,932 | 371,752 | 399,048 | 344,951 | 352,884 | 340,669 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 40,415 | 15,269 | 19,434 |
| Social insurance contributions | - | - | - | - | - | 13,836 | 8,463 | 11,658 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +48.3% | -14.3% | +45.5% | -40.4% | -2.1% | -23.5% | -31.3% | -1.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.8% | 4.8% | 21.2% | 2.6% | 5.6% | -7.1% | -0.2% | -9.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.4% | 6.4% | 26.6% | 3.4% | 7.2% | -8.6% | -0.3% | -12.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.5% | 4.3% | 16.5% | 2.3% | 5.4% | -7.7% | -0.4% | -14.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 126,907 | 103,059 | 140,146 | 79,657 | 70,290 | 51,580 | 36,958 | 33,971 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
EVOMEDA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-17 | 2025-06-19 | 188.28 |
| 2025-05-16 | 2025-06-04 | 0.21 |
| 2025-05-04 | 2025-05-11 | 0.21 |
| 2025-04-24 | 2025-04-29 | 0.21 |
| 2025-03-18 | 2025-03-20 | 193.13 |
| 2025-01-16 | 2025-02-10 | 0.21 |
| 2025-01-02 | 2025-01-08 | 0.21 |
| 2024-12-22 | 2024-12-31 | 0.21 |
| 2024-12-17 | 2024-12-20 | 0.21 |
| 2024-11-18 | 2024-12-09 | 0.21 |
| 2024-10-24 | 2024-11-06 | 0.21 |
| 2024-09-17 | 2024-09-19 | 182.25 |
| 2022-07-18 | 2022-07-19 | 0.09 |
| 2022-06-16 | 2022-07-10 | 0.09 |
| 2022-05-17 | 2022-06-09 | 0.09 |
| 2022-04-28 | 2022-05-09 | 0.09 |
| 2022-01-18 | 2022-01-19 | 97.69 |
EVOMEDA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
EVOMEDA, UAB (code 300131853) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €215.1K and recorded a net loss of €30.6K, equal to a profit margin of -14.2%. Revenue declined by 1.6% year on year and by 32.4% over two years, showing a sustained contraction from €318.1K in 2023 to €218.7K in 2024 and then to the 2025 level. Profitability weakened after a near break-even result in 2024, when the loss was only €837, following a loss of €24.5K in 2023. At the end of 2025, total assets stood at €340.7K, equity at €254.1K and liabilities at €89.9K. The equity ratio was 74.6% and debt-to-equity 0.35, indicating a conservative capital structure. Asset turnover was 0.63x, ROE was -12.0% and ROA was -9.0%. Revenue per employee was €35.9K, while profit per employee was -€5.1K.